HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,091,040 | -67.5% | 124,841 | -65.1% | 0.01% | -65.6% |
| Q2 2023 | $12,601,293 | +68.6% | 358,093 | +56.4% | 0.03% | +52.4% |
| Q1 2023 | $7,474,336 | -26.0% | 228,923 | +24.9% | 0.02% | -34.4% |
| Q4 2022 | $10,102,365 | +66.7% | 183,346 | +34.0% | 0.03% | +52.4% |
| Q3 2022 | $6,061,000 | +255.1% | 136,837 | +291.0% | 0.02% | +250.0% |
| Q2 2022 | $1,707,000 | -84.6% | 35,000 | -84.6% | 0.01% | -81.8% |
| Q1 2022 | $11,092,000 | +2159.1% | 228,000 | +1881.1% | 0.03% | +3200.0% |
| Q4 2021 | $491,000 | +72.3% | 11,509 | +45.9% | 0.00% | 0.0% |
| Q4 2020 | $285,000 | – | 7,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |